PTA Balloon Catheter Global Market Report 2024

The pta balloon catheter market size has grown rapidly in recent years. It will grow from $2.15 billion in 2023 to $2.39 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth observed in the historic period can be attributed to several factors, including patient preference for non-surgical interventions, regulatory approvals and adherence to standards, development of healthcare infrastructure, physician preference and expertise, and an increase in the prevalence of diabetes and obesity cases.

The pta balloon catheter market size is expected to see rapid growth in the next few years. It will grow to $3.57 billion in 2028 at a compound annual growth rate (CAGR) of 10.5%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing prevalence of cardiovascular diseases, the dynamics of an aging population, a heightened focus on minimally invasive procedures, rising rates of diabetes and obesity, and ongoing expansion in healthcare infrastructure.

The anticipated growth in the PTA balloon catheter market is expected to be driven by the increasing prevalence of cardiovascular disorders. Cardiovascular disorders encompass a range of conditions affecting the heart or blood vessels. The growing incidence of cardiovascular diseases necessitates advanced diagnostics and treatments, such as PTA balloon catheters, leading to an increased demand for these medical devices. For instance, in May 2023, the Centers for Disease Control and Prevention (CDC), a US-based federal agency under the Department of Health and Human Services, reported that heart disease accounted for approximately 695,000 deaths in the United States in 2021, representing 1 in every 5 deaths. The economic burden associated with heart disease reached about $239.9 billion annually from 2018 to 2019, underscoring its significant impact on public health and healthcare costs. Therefore, the rising prevalence of cardiovascular disorders is a key factor driving the growth of the PTA balloon catheter market.

The contributing factor to the market's growth is the increasing geriatric population. The geriatric population, defined as individuals aged 65 and older, has specific healthcare needs associated with aging. PTA balloon catheters play a critical role in addressing cardiovascular issues among the elderly, contributing to improved vascular health and overall well-being. For example, in October 2022, the World Health Organization (WHO), a US-based specialized health agency, projected that globally, 1 in 6 individuals would be 60 or older by 2030, and the number of elderly people is expected to reach 2.1 billion by 2050. Therefore, the growing geriatric population is a significant driver of the PTA balloon catheter market's growth.

The prevailing trend in the PTA balloon catheter market is the focus on product innovations, with major companies striving to develop advanced and unique offerings to strengthen their market positions. An example of this trend is evident in the efforts of Medtronic, an Ireland-based medical devices company. In March 2021, Medtronic introduced the chameleon PTA balloon catheter, featuring a distinctive aperture close to the balloon. This design allows for the administration of diagnostic or therapeutic fluids, such as contrast medium, directly to the treatment site. The chameleon PTA balloon catheter combines the functionalities of a conventional diagnostic catheter with a high-pressure PTA balloon, enabling simultaneous angioplasty and injection. This innovation aims to reduce volume utilization, shorten treatment and fluoroscopy times, and maintain full guidewire access.

Major companies in the PTA balloon catheter market are strategically focusing on product launches, such as the PTA balloon catheter, to serve as a unique bridge between renal and vascular divisions. A notable example is Nipro Corporation, a Japan-based medical equipment manufacturing company. In March 2022, Nipro Corporation introduced the Cronus HP PTA balloon catheter, which offers robust performance at high pressures, graduated control angioplasty using a single balloon, and enhanced ease of entry across lesions to minimize balloon dog boning. These features provide an innovative edge, addressing procedural challenges and potentially improving overall efficacy, making it a valuable tool for vascular surgeons and interventionalists.

In July 2021, Surmodics, Inc., a US-based medical device company, executed the acquisition of Vetex Medical for $39.9 million. This strategic move positions Surmodics to expedite its thrombectomy platform development for future pulmonary embolism treatments, expanding its portfolio with two FDA-approved mechanical thrombectomy devices for arterial and venous vasculature. Vetex Medical, an Iran-based company, specializes in developing innovative catheters and solutions for the removal of venous thromboembolism, contributing to Surmodics' growth and product offerings in the competitive medical device market.

Major companies operating in the pta balloon catheter market report are Cardinal Health Inc., Abbott Laboratories, Medtronic plc., Koninklijke Philips NV, Becton Dickinson and Co., Stryker Iberia, SL, Boston Scientific Corporation, Lepu Medical Technology (Beijing) Co., Ltd., B. Braun Melsungen AG, Terumo Corporation, Nipro Medical Corporation, Coloplast A/S, Teleflex Incorporated, Hellman & Friedman LLC, Cook Medical Inc., Biotronik SE & Co. KG, Smiths Medical, Merit Medical, Microport Scientific Corporation, Shockwave Medical Inc., Cardiovascular Systems Inc., Well Lead Medical Co., Ltd., Cardionovum GmbH., Surmodics Inc., Summit Medical Group Ltd., JOTEC GmbH, BACTIGUARD AB, Creagh Medical Limited, Natec Medical Ltd., TriReme Medical, Inc., Andratec GmbH, Acotec Scientific Holdings Ltd., Kaneka Corp.

North America was the largest region in the PTA balloon catheter market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pta balloon catheter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pta balloon catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of PTA balloon catheters include polyurethane and nylon. Polyurethane is a material derived from plastic in various forms, with applications spanning coronary artery disease and peripheral vascular disease. These catheters find use in various healthcare settings, including hospitals, ambulatory surgical centers, and others.

The PTA balloon catheters market research report is one of a series of new reports that provides PTA balloon catheters market statistics, including the PTA balloon catheters industry’s global market size, regional shares, competitors with a PTA balloon catheters market share, detailed PTA balloon catheters market segments, market trends and opportunities, and any further data you may need to thrive in the PTA balloon catheters industry. This PTA balloon catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The PTA balloon catheter market consists of sales of non-compliant (high-pressure) balloons, semi-compliant (mid pressure), and compliant (elastomeric) balloons. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.